Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the anti-proliferative activity on a breast-cancer cell line

International Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 411-416

  Coradini, Danila ^a   Pellizzaro, Cinzia ^a   Miglierini, Giuliana ^b   Daidone, Maria Grazia ^a   Perbellini, Alberto ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b INFN Area di Ricerca Trieste   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HERMES ANTIGEN; HYALURONIC ACID; MATRIGEL;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0032937370     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19990505)81:3<411::aid-ijc15>3.0.co;2-f     Document Type: Article

References (28)

1. CARMICHAEL, J., DEGRAFF, W.G., GAZDAR, A.F., MINNA, J.D. and MITCHELL, J.B., Evaluation of a tetrazolium-based semi-automated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47, 936-942 (1987).
2. CORADINI, D., BIFFI, A., COSTA, A., PELLIZZARO, C., PIRRONELLO, E. and DI FRONZO, G., Effects of sodium butyrate on human breast-cancer cell lines. Cell Prolif., 30, 149-159 (1997).
3. CUMMINGS, J.H., Short-chain fatty acids in the human colon. Gut, 22, 763-779 (1981).
4. DANIEL, P., BRAZIER, M., CERRUTTI, I., PIERI, F., TARDIVEL, I., DESMET, G., BAILLET, J. and CHANY, C., Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts. Clin. Chim. Acta. 181, 255-263 (1989).
5. DE BELDER, A.N. and WIK, K.O., Preparation and properties of fluorescein-labelled hyaluronate. Carbohydrate Res., 44, 251-257 (1975).
6. GUILBAUD, N.F., GAS, N., DUPONT, M.A. and VALETTE, A., Effects of differentiation-inducing agents on maturation of human MCF7 breast-cancer cells. J. cell. Physiol., 145, 162-172 (1990).
7. GUNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZOLLER, M., HAUSMANN, I., MATZKU, S., WENZEL, A., PONTA, H. and HERRLICH, P.A., New variant glycoprotein CD44 confers metastatic potential to rat-carcinoma cell. Cell, 65, 13-24 (1991).
8. HE, Q., LESLEY, J., HYMAN, R., ISHIHARA, K. and KINCADE, P.W., Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J. Cell Biol., 119, 1711-1719 (1992).
9. HILL, M.J., Bacterial fermentation of complex dietary carbohydrate in the human colon. Europ. J. Cancer Prev., 4, 897-904 (1995).
10. JASS, J.R., Diet, butyric acid and differentiation of gastrointestinal-tract tumors. Med. Hypotheses, 18, 113-118 (1985).
11. KRUPITZA, G., HARANT, H., DITTRICH, E., SZEKERES, T., HUBER, H. and DITTRICH, C., Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian-carcinoma cells. Cancerogenesis, 16, 1199-1205 (1995).
12. MANDAL, M. and KUMAR, R., bcl-2 expression regulates sodium-butyrate-induced apoptosis in human MCF7 breast-cancer cells. Cell Growth Diff., 7, 311-318 (1996).
13. MANTEN-HORST, E., DANE, E., SMIT, L., SNOEK, M., LEPOOLE, C., VAN MUIJEN G., PALS S.T. and RUTTER, D., Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int. J. Cancer, 64, 182-188 (1995).
14. MATSUMURA, Y. and TARIN, D., Significance of CD44-gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-1058 (1992).
15. MILLER, A.A., KURSCHEL, E., OSIEKA, R. and SCHMIDT, C., Clinical pharmacology of sodium butyrate in patients with acute leukemia. Europ. J. Cancer clin. Oncol., 23, 1283-1287 (1987).
16. MORIMOTO, K., ROBIN, E., LE BOUSSE-KERDILES, M.C., LI, Y., CLAY, D., JASMIN, C. and SMADJA-JOFFE, F., CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells. Blood, 83, 657-662 (1994).
17. PALMER, D.G., PARASKEVA, C. and WILLIAMS, A.C., Modulation of p53 expression in cultured colonic-adenoma cell lines by the naturally occurring lumenal factors butyrate and deoxycholate. Int. J. Cancer, 73, 702-706 (1997).
18. PLANCHON, P., POUILLART, P., RONCO, G., VILLA, P. and PIERI, F., Differential elimination of synthetic butyric triglycerides in vivo: a pharmacokinetic study. J. pharm. Sci., 82, 1046-1048 (1993).
19. POUILLART, P., RONCO, G., CERUTTI, I., TROUVIN, J.H., PIERI, F. and VILLA, P., Pharmacokinetic studies of N-butyric-acid mono-and polyester derived from monosaccharides. J. pharm. Sci., 81, 241-244 (1992).
20. REPHAELI, A., RABIZADEH, E., AVIRAM, A., SHAKLAI, M., RUSE, M. and NUDELMAN, A., Derivatives of butyric acid as potential anti-neoplastic agents. Int. J. Cancer, 49, 66-72 (1991).
21. ROTTLEB, C., BORNKAMM, G.W. and POLACK, A., Among 17 inducers of differentiation only sodium butyrate causes a permanent down-regulation of c-myc in Burkitt's lymphoma. Int. J. Cancer, 62, 697-702 (1995).
22. RUDZKI, Z. and JOTHY, S., CD44 and the adhesion of neoplastic cells. J. clin. Pathol.: mol. Pathol., 50, 57-71 (1997).
23. SEALY, L. and CHALKLEY, R., The effect of sodium butyrate on hystone modification. Cell, 14, 115-121 (1978).
24. SOULE, H.D., VAZQUES, J. and LONG, A., A human cell line from a pleural effusion derived from a breast carcinoma. J. nat. Cancer Inst., 51, 1409-1416 (1973).
25. TOSCANI, A., SOPRANO, D.R., and SOPRANO, K.J., Molecular analysis of sodium butyrate-induced growth arrest. Oncogene Res., 3, 223-238 (1988).
26. VELAZQUEZ, O.C., ZHOU, D., SETO, R.W., JABBAR, A., CHOI, J., LEDERER, H.M. and ROMBEAU, J.L., In vivo crypt surface hyperproliferation is decreased by butyrate and increased by deoxycholate in normal rat colon: associated in vivo effects on c-fos and c-jun expression. J. parenter. enter. Nutr., 20, 243-250 (1996).
27. VIDALI, G., BOFFA, L.C., BRADBURY, E.M. and ALLFREY, F.G., Butyrate suppression of histone deacetylation leads to accumulation of polyacetylated forms of H3 and H4 and increased DNase-1 sensitivity of associated DNA sequences. Proc. nat. Acad. Sci. (Wash.), 75, 2239-2243 (1978).
28. ZIMRAH, Y., WASSERMAN, L., MARON, L., SHAKLAI, M., NUDELMAN, A. and REPHAELI, A., Butyric acid and pivaloyloxymethyl butyrate, AN9, a novel butyric-acid derivative, induce apoptosis in HL60 cells. J. Cancer Res. din. Oncol., 123, 152-160 (1997).